Home › Research › Topics › costs
costs
265 studies tagged costs, dated 1989-11-10 to 2026-10-28. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- The Contribution of Routinely Collected Clinical Data to Dementia Identification in Primary Care: A Cross-Sectional Study 2026-10-28
- Racial Differences and Temporal Trends in Parkinson’s and Alzheimer’s Disease-Related 2026-10-24
- Prognostic heterogeneity within cognitive stages: a nationwide cohort study of everyday functional difficulties and mortality in 202,508 older adults 2026-10-23
Studies
265 studies carry this tag.
Date range
1989 to 2026
Top journals
- Alzheimer's & dementia : the journal of the Alzheimer's Association 38
- Journal of the American Geriatrics Society 21
- medRxiv 19
- Journal of Alzheimer's disease : JAD 15
- Research Square 15
104 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
This review corroborates previous understanding that AD burden is high for both society and healthcare providers.
-
Alzheimer's disease (AD) extracts a heavy societal toll.
-
67/100
Dementia is among various diseases affecting the elderly, who is also at a high risk for fractures.
-
Recent studies have been cautiously optimistic about declining trends in dementia prevalence and incidence.
-
The results should form the basis for future health policy decisions on the treatment of patients with multiple chronic diseases and also show the need to introduce new ways of providing long-term care to this population.
-
As the US elderly population continues to expand rapidly, Alzheimer's disease poses a major and increasing public health challenge, and older African Americans may be disproportionately burdened by the disease.
-
Over the past two decades the collaborative care model within primary care has proved to be effective in improving care quality, efficiency, and outcomes for older adults suffering from dementia and depression.
-
Hospitalizations and emergency department (ED) visits for people with Alzheimer's disease and related disorders are of particular concern because many of these patients are physically and mentally frail, and the care delivered in these settings is costly.
-
The analysis of the comorbidities associated with an index disease (e.g., dementia) must not be exclusively based on prevalence rates, but rather on methodologies that allow the discovery of non-random associations between diseases.
-
More than half of nursing home residents suffer from dementia, which is about 19-fold higher than the prevalence in insured living in the community.
-
Preventable hospital readmissions have been recognized as indicators of hospital quality, a source of increased healthcare expenditures, and a burden for patients, families, and caregivers.
-
Individuals with AD comprise a substantial number of older adult deaths in the United States, a number expected to rise considerably in coming decades.
-
A history of previous exposure to surgery under GA might be associated with an increased risk of dementia, particularly in subjects who have undergone repeated exposure to GA.
-
Earlier treatment leads to a small delay in institutionalization among AD patients, resulting in significant costs savings to Medicaid.
-
As the U.S. population ages, the burden of neurodegenerative disorders, including Alzheimer disease and Parkinson disease, will increase substantially.
-
The value of screening for cognitive impairment, including dementia and Alzheimer's disease, has been debated for decades.
-
When using ethnic group-specific norms, NP and functional abilities predicted diagnosis in both groups with no significant differences but BPS was only significant in Hispanics.
-
Medicare beneficiaries with ADRD were at a higher risk of PAHs for certain uncontrolled comorbidities and incurred higher Medicare expenditures compared with matched controls without dementia.
-
Individuals aged 68+ years diagnosed with OAG have a decreased rate of AD or other dementia diagnosis compared to control patients without an OAG diagnosis.
-
Under Medicare Part D, senior citizens choose prescription drug insurance offered by numerous private insurers.
-
Patients with CKD could have an elevated dementia risk.
-
67/100
The findings of this study suggest an increased risk of dementia among individuals with TBI.
-
Dementia poses a substantial additional burden to the German social security system, with the long-term care sector being more seriously challenged than the health care sector.
-
Just under a half of the expected numbers of patients with dementia are recognised in GP dementia registers.
-
We conclude that dementia and cognitive impairment are common among older adults with hip fractures.
-
Alzheimer's disease (AD) is the sixth leading cause of all deaths in the United States and is the fifth leading cause of death in Americans aged ≥65 years.
-
Median survival was much lower than in screened populations.
-
Different information sources yield widely varied prevalence and expenditure estimates.
-
Service utilization by demented patients increases already within the year before the first diagnosis and stays on a relatively high level within the year after.
-
The worldwide cost of dementia has increased by 34% (18% in fixed prices) between 2005 and 2009.
-
The new services would cost around pound sterling 220 million extra per year nationally in England.
-
These findings indicate that the early diagnosis and treatment of AD are not only socially desirable in terms of increasing economic efficiency, but also fiscally attractive from both state and federal perspectives.
-
Alzheimer disease (AD) is a growing public health problem that disproportionately affects racial and ethnic minorities, including African Americans.
-
Patients with AD have significantly more co-morbid medical conditions and higher healthcare costs and utilization than demographically-matched Medicare beneficiaries.
-
Few studies have examined the disease burden of AD in commercial managed care settings.
-
On average, ADRD diagnosis was not significantly associated with excess Medicare payments over the last 5 years of life.
-
Alzheimer's disease is the seventh leading cause of all deaths in the United States and the fifth leading cause of death in Americans older than the age of 65 years.
-
Mini-Cog screening by office staff is feasible in primary care practice and has measurable effects on physician behavior.
-
Worldwide costs for dementia are enormous, and informal care constitutes a major cost component, in particular in less developed regions.
-
ementia refers to a syndrome that is characterised by progressive deterioration of cognitive functions.
-
This study explores whether nursing home residents with Alzheimer's disease and related dementias (ADRD) are affected differently by facility-level risk factors of ambulatory care-sensitive (ACS) conditions, a measure of timely access to medical care.
-
Having an exam reflects multiple factors.
-
The National Alzheimer's Coordinating Center (NACC) is responsible for developing and maintaining a database of patient information collected from the 29 Alzheimer disease centers (ADCs) funded by the National Institute on Aging.
-
Existing evidence regarding diagnostic disclosure in dementia is both inconsistent and limited with the perspectives of people with dementia being largely neglected.
-
An estimated four million individuals in the United States have Alzheimer's disease (AD).
-
Comorbidity associated with parkinsonism is an under-recognized contribution to higher resource use and expenditures.
-
We linked Medicare claims data to information on 417 patients with a clinical diagnosis of Alzheimer's disease in the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) to determine what proportion of them were identified as having Alzheimer's disease (AD) in Medicare claims records.
-
Utilization and costs for patients with AD were higher compared to controls and were substantially higher for patients with both AD and co-morbid diseases commonly targeted for disease management.
-
Despite the limitation of a cross-sectional design, our initial findings suggest that there is a strong association between medical comorbidity and cognitive status in AD.
-
53/100
In this study, prevalence rates for ADRD mirrored population estimates.
From across this tag
9 of the 265 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 9. The same 9 appear here every time.
- Post-disclosure distress among racial and ethnic groups in a preclinical AD trial
- Poorer outcomes and greater healthcare costs for hospitalised older people with dementia and delirium: a retrospective cohort study
- Programme Dementia Prevention (pdp): A Nationwide Program for Personalized Prevention in Luxembourg
- Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana
- Predictors of falls in older adults with and without dementia
- Black-White Disparities in Moves to Assisted Living and Nursing Homes Among Older Medicare Beneficiaries
- Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons
- Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need
- Screening for intrinsic capacity impairments as markers of increased risk of frailty and disability in the context of integrated care for older people: Secondary analysis of MAPT